Our Team

David joined Fixed Phage in July of 2019. David, as CEO, is involved in every aspect of the business, from developing the business strategy to washing the coffee mugs. David has over 40 years of experience in healthcare innovation, having worked for the NHS, large blue-chip companies such as J&J and Philips, as well as university spinouts focusing on precision medicine for cancer.
Working with highly motivated teams and partners, applying innovation to solve healthcare challenges, and making an impact on the healthcare industry are among his professional interests.

Personal interests include competing internationally as an off-road multi-sport athlete (usually swimming, mountain biking and off-road running). David arrived at Fixed Phage on his first day with his ankle in support - boot.

Dr Clark is a leading industrial phage scientist who has worked in phage companies for over ten years. He has extensive experience manufacturing phages to GMP standards.

Dr Clark is a microbiologist with a PhD.

Chris has 25 years of Blue-Chip Pharmaceutical and Consumer Healthcare experience, R&D-led operational management, and Lean Six Sigma practitioner (Black Belt).

Marta started working for Fixed Phage in May 2021 as Finance and Business Administration Manager, taking responsibility for the monthly financial reporting, financial planning, budgeting and forecasting, as well as other operational duties, having previously worked at Sainsbury’s bank in a similar role, formerly an auditor at Pricewaterhouse Coopers, with an overall financial experience of around 7 years.

Professional interests consist of business valuations, project costings, financial modelling and wider economics, with Fixed Phage providing a great opportunity to tap into all areas of pursuit, as well as broader prospects for professional development.

Personal interests span from stocks and shares trading and cryptocurrency assets to art. Marta is also keen on environmentalism and chooses cycling to work over owning a car.

Neil started at Fixed Phage in May 2022, expanding the company’s commercial activity, and generating sustainable revenue, while accelerating market access through licencing and strategic partnerships.
Neil was previously head of commercialisation and innovation at Scotland’s Rural College (SRUC). An accomplished commercial professional with experience in business development, deal structure and company creation from scientific research output, having established a strong track record in identifying and developing innovative commercial opportunities within complex scientific output and environments.

He holds a PhD in quantitative genetics and a degree in agricultural science. His professional interests over 20 years across business and academia have equipped him with wide-ranging skillset, this has enabled him to gain considerable experience in building long-lasting relationships with partner companies and key stakeholders at the National and International levels.

Neil has a passion for supporting the vibrant and innovative life sciences ecosystem, entrepreneurs, and businesses, and actively does this through non-executive director roles and has a particular interest in supporting and developing future leaders.

Neil is a very keen golfer and enjoys keeping fit and improving his golf game through CrossFit, balancing busy home life with two young children and regular amateur golf competitions.

Through Barwell Consulting Limited, Alec serves as Finance Director and Company Secretary. Alec is the Managing Director of Barwell Plc and has extensive experience investing in high-growth start-ups and emerging technology companies.

Dr Mike Mattey is a world-leading expert in phage research. He is the founder of Fixed Phage and an Inventor of technology.

Trevor is an experienced manager with an entrepreneurial spirit who has built a number of bioscience-based product and service companies from the ground up. He enjoys the challenges of this environment, especially working in groups of like-minded people.

Albert is an accomplished business leader with extensive experience delivering and advising on global healthcare operations. Strategically focused, with strengths in delivering significant quantifiable transformational improvements, restructuring operations, and developing high-calibre personnel to ensure continuous growth, competitive superiority, and profit maximisation.

Albert retired from global medical device companies 10 years ago to focus on assisting early-stage businesses in driving commercialization and raising external financing. Mentoring founding teams is an important strength in ensuring that they are best positioned to deliver on their business plan and increase shareholder value.

Simon has a background in corporate law and venture capital in both early and late stage companies/private equity investments and has extensive experience in creating and realising long-term value through a business building, mergers and acquisitions of both private and public companies, and fundraising. He previously worked for Macfarlanes and Gouldens and Gartmore Investment Management.

Daniel joined the team in 2015 as a Laboratory Scientist after earning an MSc in Biotechnology and a BSc Hons in Biology and Chemistry from the Universities of Glasgow and Malta.
Daniel was promoted to Senior Scientist in 2021 and is now primarily responsible for the Technology Optimisation Programme as well as line management of junior members of staff. Daniel is also studying for a company-sponsored PhD at the University of Strathclyde.
Professional interests include bacteriophage formulation immobilisation and stabilisation on polymeric surfaces.

Daniel enjoys playing the guitar in his spare time and is a big fan of jazz and blues music.

After completing his PhD at the University of Glasgow, Gordon was hired as the second lab-based employee at Fixed Phage joining in late 2011. Initially assisting with the projects, Gordon has since
grown within the company into a senior scientist where he has led multiple successful collaborative and development projects.

Following on from a PhD in decontamination of medical instruments, Gordon has a particular interest in the application of phages to control bacterial biofilms in multiple environments as well as
using phages to improve animal health. This includes the design and implementation of biofilm models to provide appropriate, phage-specific, efficacy testing.

When not having fun with his two boys, Gordon enjoys organising recreational football matches, a good board game and the care and breeding of saltwater fish.

Emma has been a part of Fixed Phage since its inception in 2011. As a result, she is in a unique position to have witnessed the company's transformation from a small aspiring company to a larger organisation working in multiple areas. Emma leads several critical projects at Fixed Phage and manages the laboratory scientists as a principal scientist. She has worked with bacteriophages for over 16 years. Her PhD research focused on bacteriophages, specifically the ecology and genetics of phages in soil systems.

She then moved on to civil engineering, where she discovered naphthalene-degrading bacteria and their phages. Emma is a dedicated genealogist who specialises in genomic genealogy. Every weekend, she goes hillwalking with her family and two dogs.

In July 2021, Albulena began working as a Laboratory Scientist at Fixed Phage. Her responsibilities include experiment design and implementation, as well as reporting results and accomplishments to partners.
Prior to joining Fixed Phage, Albulena oversaw the structural planning and establishment of a new soil microbiology laboratory at the Kosovo Agricultural Institute.
Albulena has a biotechnology and food engineering background, as well as international academic and industry experience.
Professional interests include assessing and optimising the phage effect on biofilm disruption.

Albulena's personal interests include music, particularly singing; she has won numerous awards in various singing competitions in her home country. She is also a cinephile who enjoys alternative cinematography.

Scott began working for Fixed Phage on November 11, 2020, with his primary role as a senior scientist. He has also been designated as a biosafety officer.
Scott has worked as a fermentation scientist, biocatalyst analyst, inorganic chemist, and molecular biologist over the course of his career, totalling 10 years in the industry.
Professional interests include the intersection of the green and white biotechnology sectors, as well as the development of applications that combine the two.

Personal interests include hiking in the mountains with his partner and their Chow Chow dog.